The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Davydov O.S.

Research Institute of General Pathology and Pathophysiology

Glebov M.V.

Buyanov Clinical Hospital of the Moscow Healthcare Department

Fibromyalgia

Authors:

Davydov O.S., Glebov M.V.

More about the authors

Journal: Russian Journal of Pain. 2020;18(3): 66‑74

DOI: 10.17116/pain20201803166

Views: 17945

Downloaded: 787

Download PDF (RU)
Contact the author
Table of contents

FIBROMYALGIA
FIBROMYALGIA

To cite this article:

Davydov OS, Glebov MV. Fibromyalgia. Russian Journal of Pain. 2020;18(3):66‑74. (In Russ.)
https://doi.org/10.17116/pain20201803166

 
 
Подписка 2025-2 (Russian Journal of Pain)
МСФ на ЯМ
Close metadata
Recommended articles:
Pathogenetic, clinical-diagnostic and therapeutic aspe­cts of premenstrual syndrome. Russian Bulletin of Obstetrician-Gynecologist. 2024;(2):37-42
Morphological features of vaso­proliferative tumor of the retina. Russian Journal of Archive of Pathology. 2024;(2):42-50
Clinical and morphological asse­ssment of patients with adenomyosis: own data. Russian Journal of Human Reproduction. 2024;(2):130-135
Features of the clinical and neuroimaging picture in patients with early-onset Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):56-63
Cognitive impairment in multiple system atro­phy — exclusion criteria or an inte­gral part of the clinical picture?. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):86-91
B vita­mins and diseases of the peri­pheral nervous system. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):75-82
A case report of anti-NMDA rece­ptor ence­phalitis with mental disturbances mani­festation. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):142-144
Physical methods of correction of arte­rial hype­rtension: modern concepts. (A lite­rature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(3):41-47
Pharmacotherapy of schi­zophrenia: clinical and some age-related aspe­cts. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):41-50
The diagnostic effe­ctiveness of criteria for neuromyelitis optica spectrum diso­rders in the Russian clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):16-25

Fibromyalgia is characterized by a combination of chronic widespread muscle pain and various concomitant psychosomatic symptoms such as fatigue, sleep disturbances, general stiffness, depression, anxiety and cognitive disorders. The prevalence of fibromyalgia in general population varies from 2% to 4%. Despite the achievements of recent decades, fibromyalgia is still a poorly diagnosed and difficult-to-treat disease. The purpose of this review is to summarize recent literature data on pathogenesis, diagnosis, clinical presentation, evidence-based methods of pharmacotherapy and non-drug treatment of fibromyalgia.

Keywords:

fibromyalgia
pathogenesis
diagnostic criteria
clinical presentation
pharmacotherapy
non-drug treatment

Authors:

Davydov O.S.

Research Institute of General Pathology and Pathophysiology

Glebov M.V.

Buyanov Clinical Hospital of the Moscow Healthcare Department

Received:

15.07.2020

Accepted:

28.07.2020

List of references:

  1. Inanici F, Yunus MB. History of fibromyalgia: past to present. Current Pain and Headache Reports. 2004;8(5):369-378.  https://doi.org/10.1007/s11916-996-0010-6
  2. Hench PK. Nonarticular rheumatism, 22nd rheumatism review: review of the American and English literature for the years 1973 and 1974. Arthritis and Rheumatology. 1976;19(suppl):1081-1089.
  3. Smythe HA. Nonarticular rheumatism and psychogenic musculoskeletal syndromes. In: Arthritis and Allied Conditions. Edn 8. Edited by McCarty DJ. Philadelphia: Lea and Febiger; 1972.
  4. Moldofsky H, Scarisbrick P, England R, Smythe H: Musculoskeletal symptoms and non-REM sleep disturbance in patients with «fibrositis syndrome» and healthy subjects. Psychosomatic Medicine. 1975;37(4):341-351.  https://doi.org/10.1097/00006842-197507000-00008
  5. Smythe HA, Moldofsky H. Two contributions to understanding of the «fibrositis» syndrome. Bulletin on the Rheumatic Diseases. 1977;28(1):928-931. 
  6. Yunus MB. Primary fibromyalgia syndrome: current concepts. Comprehensive Therapy. 1984;10(8):21-28. 
  7. Yunus MB. Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation. The Journal of Rheumatology. 1992;19(6):846-850. 
  8. Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: development and validation. The Journal of Rheumatology. 1991; 18(5):728-733. 
  9. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism. 1990;33(2): 160-172.  https://doi.org/10.1002/art.1780330203
  10. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. The Journal of Rheumatology. 2011;38(6):1113-1122. https://doi.org/10.3899/jrheum.100594
  11. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, Mease PJ, Russell AS, Russell IJ, Walitt B. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Seminars in Arthritis and Rheumatism. 2016; 46(3):319-329.  https://doi.org/10.1016/j.semarthrit.2016.08.012
  12. Galvez-Sánchez CM, Reyes Del Paso GA. Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives. Journal of Clinical Medicine. 2020;9(4):1219. https://doi.org/10.3390/jcm9041219
  13. Häuser W, Sarzi-Puttini P, Fitzcharles MA. Fibromyalgia syndrome: under-, over- and misdiagnosis. Clinical and Experimental Rheumatology. 2019;37 (suppl 116) (1):90-97. 
  14. Queiroz LP. Worldwide epidemiology of fibromyalgia. Current Pain and Headache Reports. 2013;17(8):356.  https://doi.org/10.1007/s11916-013-0356-5
  15. McBeth J, Jones K. Epidemiology of chronic musculoskeletal pain. Best Practice and Research. Clinical Rheumatology. 2007;21(3):403-425.  https://doi.org/10.1016/j.berh.2007.03.003
  16. Jones GT, Atzeni F, Beasley M, Flüß E, Sarzi-Puttini P, Macfarlane GJ. The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis and Rheumatology. 2015;67(2):568-575.  https://doi.org/10.1002/art.38905
  17. Wolfe F, Ross K, Anderson J, Russell IJ. Aspects of fibromyalgia in the gene-ral population: Sex, pain threshold, and fibromyalgia symptoms. The Journal of Rheumatology. 1995;22(1):151-156. 
  18. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and cha-racteristics of fibromyalgia in the general population. Arthritis and Rheumatism. 1995;38(1):19-28.  https://doi.org/10.1002/art.1780380104
  19. Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, Starck LO, Keck PE Jr. Family study of fibromyalgia. Arthritis and Rheumatism. 2004;50(3):944-952.  https://doi.org/10.1002/art.20042
  20. Knight T, Schaefer C, Chandran A, Zlateva G, Winkelmann A, Perrot S. Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States. ClinicoEconomics and Outcomes Research: CEOR. 2013; 5:171-180.  https://doi.org/10.2147/CEOR.S41111
  21. Duffield SJ, Miller N, Zhao S, Goodson NJ. Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis. Rheumatology (Oxford, England). 2018;57(8):1453-1460. https://doi.org/10.1093/rheumatology/key112
  22. Baraliakos X, Regel A, Kiltz U, Menne HJ, Dybowski F, Igelmann M, Kalthoff L, Krause D, Saracbasi-Zender E, Schmitz-Bortz E, Braun J. Patients with fibromyalgia rarely fulfil classification criteria for axial spondyloarthritis. Rheumatology (Oxford, England). 2018;57(9):1541-1547. https://doi.org/10.1093/rheumatology/kex318
  23. Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, Cohen M, Evers S, Finnerup NB, First MB, Giamberardino MA, Kaasa S, Korwisi B, Kosek E, Lavandʼhomme P, Nicholas M, Perrot S, Scholz J, Schug S, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019;160(1):19-27.  https://doi.org/10.1097/j.pain.0000000000001384
  24. Aaron LA, Buchwald D. Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. Best Practice and Research. Clinical Rheumatology. 2003;17(4):563-574.  https://doi.org/10.1016/s1521-6942(03)00033-0
  25. Yunus MB. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Seminars in Arthritis and Rheumatism. 2008;37(6):339-352.  https://doi.org/10.1016/j.semarthrit.2007.09.003
  26. Bradley LA. Pathophysiology of fibromyalgia. The American Journal of Medicine. 2009;122(12 suppl):22-30.  https://doi.org/10.1016/j.amjmed.2009.09.008
  27. Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis and Rheumatism. 2002;46(5):1333-1343. https://doi.org/10.1002/art.10225
  28. Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Javors MA, Bowden CA. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. The Journal of Rheumatology. 1992;19(1):104-109. 
  29. Russell IJ, Vaeroy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis and Rheumatism. 1992;35(5):550-556.  https://doi.org/10.1002/art.1780350509
  30. Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA, Sternberg EM, Gold PW, Chrousos GP, Wilder RL. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis and Rheumatism. 1994;37(11):1583-1592. https://doi.org/10.1002/art.1780371105
  31. Di Franco M, Iannuccelli C, Valesini G. Neuroendocrine immunology of fibromyalgia. Annals of the New York Academy of Sciences. 2010; 1193:84-90.  https://doi.org/10.1111/j.1749-6632.2009.05344.x
  32. Romano GF, Tomassi S, Russell A, Mondelli V, Pariante CM. Fibromyalgia and chronic fatigue: the underlying biology and related theoretical issues. Advances in Psychosomatic Medicine. 2015; 34:61-77.  https://doi.org/10.1159/000369085
  33. Casale R, Sarzi-Puttini P, Botto R, Alciati A, Batticciotto A, Marotto D, Torta R. Fibromyalgia and the concept of resilience. Clinical and Experimental Rheumatology. 2019;(37 suppl):116(1):105-113. 
  34. Hjemdal O, Friborg O, Stiles TC. Resilience is a good predictor of hopelessness even after accounting for stressful life events, mood and personality (NEO-PI-R). Scandinavian Journal of Psychology. 2012;53(2):174-180.  https://doi.org/10.1111/j.1467-9450.2011.00928.x
  35. Southwick SM, Vythilingam M, Charney DS. The psychobiology of depression and resilience to stress: implications for prevention and treatment. Annual Review of Clinical Psychology. 2005; 1:255-291.  https://doi.org/10.1146/annurev.clinpsy.1.102803.143948
  36. Häuser W, Ablin J, Fitzcharles MA, Littlejohn G, Luciano JV, Usui C, Walitt B. Fibromyalgia. Nature Reviews. Disease Primers. 2015; 1:15022. https://doi.org/10.1038/nrdp.2015.22
  37. Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nature Reviews. Microbiology. 2012;10(11):735-742.  https://doi.org/10.1038/nrmicro2876
  38. Clos-Garcia M, Andrés-Marin N, Fernández-Eulate G, Abecia L, Lavín JL, van Liempd S, Cabrera D, Royo F, Valero A, Errazquin N, Vega MCG, Govillard L, Tackett MR, Tejada G, Gónzalez E, Anguita J, Bujanda L, Orcasitas AMC, Aransay AM, Maíz O, López de Munain A, Falcón-Pérez JM. Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia. EBioMedicine. 2019;46:499-511.  https://doi.org/10.1016/j.ebiom.2019.07.031
  39. Grayston R, Czanner G, Elhadd K, Goebel A, Frank B, Üçeyler N, Malik RA, Alam U. A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: Implications for a new paradigm in fibromyalgia etiopathogenesis. Seminars in Arthritis and Rheumatism. 2019; 48(5):933-940.  https://doi.org/10.1016/j.semarthrit.2018.08.003
  40. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, Russell IJ, Yunus MB. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis and Rheumatism. 1997; 40(9):1560-1570. https://doi.org/10.1002/art.1780400904
  41. Goldenberg DL. Diagnosis and differential diagnosis of fibromyalgia. American Journal of Medicine. 2009;122(12 suppl):14-21.  https://doi.org/10.1016/j.amjmed.2009.09.007
  42. Russell IJ, Bieber CS. Myofascial pain and fibromyalgia syndrome. In: McMahon SB, Koltzenburg M, eds. Melzack and Wall’s textbook of pain. 5th ed. Edinburgh: Churchill Livingstone; 2005.
  43. Brummett CM, Janda AM, Schueller CM, Tsodikov A, Morris M, Williams DA, Clauw DJ. Survey criteria for fibromyalgia independently predict increased postoperative opioid consumption after lower-extremity joint arthroplasty: a prospective, observational cohort study. Anesthesiology. 2013;119(6): 1434-1443. https://doi.org/10.1097/ALN.0b013e3182a8eb1f
  44. Arnold LM. Management of psychiatric comorbidity in fibromyalgia. Current Psychiatry Reports. 2006;8(3):241-245.  https://doi.org/10.1007/s11920-006-0030-2
  45. Häuser W, Ablin J, Perrot S, Fitzcharles MA. Management of fibromyalgia: practical guides from recent evidence-based guidelines. Polish Archives of Internal Medicine. 2017;127(1):47-56.  https://doi.org/10.20452/pamw.3877
  46. Hoppenfeld DD. Diagnostika i lechenie boli. Per. s angl. Pod red. Davydova O.S. M.: MEDpress-inform; 2019.
  47. Häuser W, Jung E, Erbslöh-Möller B, Gesmann M, Kühn-Becker H, Petermann F, Langhorst J, Weiss T, Winkelmann A, Wolfe F. Validation of the Fibromyalgia Survey Questionnaire within a cross-sectional survey. PloS One. 2012;7(5): e37504. https://doi.org/10.1371/journal.pone.0037504
  48. Perrot S, Bouhassira D, Fermanian J; Cercle d’Etude de la Douleur en Rhumatologie. Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST). Pain. 2010;150(2):250-256.  https://doi.org/10.1016/j.pain.2010.03.034
  49. Danilov AB. Diagnostika i lechenie fibromialgii. Lechashchij vrach. 2012;5. Accessed June 20, 2020. https://www.lvrach.ru/2012/05/15435422
  50. Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, Choy E, Kosek E, Amris K, Branco J, Dincer F, Leino-Arjas P, Longley K, McCarthy GM, Makri S, Perrot S, Sarzi-Puttini P, Taylor A, Jones GT. EULAR revised recommendations for the management of fibromyalgia. Annals of the Rheumatic Diseases. 2017;76(2):318-328.  https://doi.org/10.1136/annrheumdis-2016-209724
  51. Fitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choinière M, Ko G, Moulin DE, Panopalis P, Proulx J, Shir Y. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Research and Management. 2013;18(3):119-126.  https://doi.org/10.1155/2013/918216
  52. Silva AR, Bernardo A, Costa J, Cardoso A, Santos P, de Mesquita MF, Vaz Patto J, Moreira P, Silva ML, Padrão P. Dietary interventions in fibromyalgia: a systematic review. Annals of Medicine. 2019;51(sup 1):2-14.  https://doi.org/10.1080/07853890.2018.1564360
  53. Lawson K. A Brief Review of the Pharmacology of Amitriptyline and Clinical Outcomes in Treating Fibromyalgia. Biomedicines. 2017;5(2):24.  https://doi.org/10.3390/biomedicines5020024
  54. de Farias ÁD, Eberle L, Amador TA, da Silva Dal Pizzol T. Comparing the efficacy and safety of duloxetine and amitriptyline in the treatment of fibromyalgia: overview of systematic reviews. Advances in Rheumatology (London, England). 2020;60(1):35.  https://doi.org/10.1186/s42358-020-00137-5
  55. Welsch P, Üçeyler N, Klose P, Walitt B, Häuser W. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. The Cochrane Database of Systematic Reviews. 2018;2(2):CD010292. https://doi.org/10.1002/14651858.CD010292.pub2
  56. Cording M, Derry S, Phillips T, Moore RA, Wiffen PJ. Milnacipran for pain in fibromyalgia in adults. The Cochrane Database of Systematic Reviews. 2015;2015(10):CD008244. https://doi.org/10.1002/14651858.CD008244.pub3
  57. Gaynor P, McCarberg B, Zheng W, Shoemaker S, Duena. Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies. Int J Clin Pract. 2011;65(3):341-349.  https://doi.org/10.1111/j.1742-1241.2011.02635.x
  58. Arnold LM, Palmer RH, Hufford MR, Chen W. Effect of milnacipran on body weight in patients with fibromyalgia. Int J Gen Med. 2012; 5:879-887. Epub 2012 Oct 18.  https://doi.org/10.2147/IJGM.S36444
  59. Üçeyler N, Sommer C, Walitt B, Häuser W. Anticonvulsants for fibromyalgia. The Cochrane Database of Systematic Reviews. 2017;10(10):CD010782. https://doi.org/10.1002/14651858.CD010782.pub2
  60. Arnold LM, Choy E, Clauw DJ, Oka H, Whalen E, Semel D, Pauer L, Knapp L. An evidence-based review of pregabalin for the treatment of fibromyalgia. Current Medical Research and Opinion. 2018;34(8):1397-1409. https://doi.org/10.1080/03007995.2018.1450743
  61. da Rocha AP, Mizzaci CC, Nunes Pinto ACP, da Silva Vieira AG, Civile V, Trevisani VFM. Tramadol for management of fibromyalgia pain and symptoms: Systematic review. International Journal of Clinical Practice. 2020;74(3): e13455. https://doi.org/10.1111/ijcp.13455
  62. Tofferi JK, Jackson JL, O’Malley PG. Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis. Arthritis and Rheumatism. 2004;51(1):9-13.  https://doi.org/10.1002/art.20076
  63. Caron J, Kaye R, Wessel T, Halseth A, Kay G. An assessment of the centrally acting muscle relaxant tolperisone on driving ability and cognitive effects compared to placebo and cyclobenzaprine. Journal of Clinical Pharmacy and Therapeutics. 2020;45(4):774-782.  https://doi.org/10.1111/jcpt.13165
  64. Walitt B, Klose P, Üçeyler N, Phillips T, Häuser W. Antipsychotics for fibromyalgia in adults. The Cochrane Database of Systematic Reviews. 2016; 2016(6):CD011804. https://doi.org/10.1002/14651858.CD011804.pub2
  65. Calandre EP, Morillas-Arques P, Molina-Barea R, Rodriguez-Lopez CM, Rico-Villademoros F. Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study. BMC Musculoskeletal Disorders. 2011; 12:95.  https://doi.org/10.1186/1471-2474-12-95
  66. Stockings E, Campbell G, Hall WD, Nielsen S, Zagic D, Rahman R, Murnion B, Farrell M, Weier M, Degenhardt L. Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies. Pain. 2018;159(10):1932-1954. https://doi.org/10.1097/j.pain.0000000000001293
  67. Chinn S, Caldwell W, Gritsenko K. Fibromyalgia Pathogenesis and Treatment Options Update. Current Pain and Headache Reports. 2016;20(4):25.  https://doi.org/10.1007/s11916-016-0556-x
  68. Thorpe J, Shum B, Moore RA, Wiffen PJ, Gilron I. Combination pharmacotherapy for the treatment of fibromyalgia in adults. The Cochrane Database Of Systematic Reviews. 2018;2(2):CD010585. https://doi.org/10.1002/14651858.CD010585.pub2

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.